Risk factors and nomogram-based prediction of the risk of limb weakness in herpes zoster

Shao-Jun Li; Dan Feng

doi:10.3389/fnins.2023.1109927

Risk factors and nomogram-based prediction of the risk of limb weakness in herpes zoster

Front Neurosci. 2023 Mar 13:17:1109927. doi: 10.3389/fnins.2023.1109927. eCollection 2023.

Authors

Shao-Jun Li¹, Dan Feng¹

Affiliation

¹ Department of Pain Management, Wuhan No.1 Hospital, Wuhan, Hubei, China.

Abstract

Background: Limb weakness is a less common complication of herpes zoster (HZ). There has been comparatively little study of limb weakness. The aim of this study is to develop a risk nomogram for limb weakness in HZ patients.

Methods: Limb weakness was diagnosed using the Medical Research Council (MRC) muscle power scale. The entire cohort was assigned to a training set (from January 1, 2018 to December 30, 2019, n = 169) and a validation set (from October 1, 2020 to December 30, 2021, n = 145). The least absolute shrinkage and selection operator (LASSO) regression analysis method and multivariable logistic regression analysis were used to identify the risk factors of limb weakness. A nomogram was established based on the training set. The discriminative ability and calibration of the nomogram to predict limb weakness were tested using the receiver operating characteristic (ROC) curve, calibration plots, and decision curve analysis (DCA). A validation set was used to further assess the model by external validation.

Results: Three hundred and fourteen patients with HZ of the extremities were included in the study. Three significant risk factors: age (OR = 1.058, 95% CI: 1.021-1.100, P = 0.003), VAS (OR = 2.013, 95% CI: 1.101-3.790, P = 0.024), involving C6 or C7 nerve roots (OR = 3.218, 95% CI: 1.180-9.450, P = 0.027) were selected by the LASSO regression analysis and the multivariable logistic regression analysis. The nomogram to predict limb weakness was constructed based on the three predictors. The area under the ROC was 0.751 (95% CI: 0.673-0.829) in the training set and 0.705 (95% CI: 0.619-0.791) in the validation set. The DCA indicated that using the nomogram to predict the risk of limb weakness would be more accurate when the risk threshold probability was 10-68% in the training set and 15-57% in the validation set.

Conclusion: Age, VAS, and involving C6 or C7 nerve roots are potential risk factors for limb weakness in patients with HZ. Based on these three indicators, our model predicted the probability of limb weakness in patients with HZ with good accuracy.

Keywords: herpes zoster; limb weakness; nomogram; risk factors; treatment.